11 Steven Cohen Fate Therapeutics Trades
Steven Cohen's position in Fate Therapeutics is currently worth $18.4 Million. That's 0.06% of their equity portfolio (380th largest holding). The investor owns 3.11% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q1 2019. Since then Steven Cohen bought shares six more times and sold shares on four occasions. The stake costed the investor $8.33 Million, netting the investor a gain of 121% so far.
Avg closing price
Price range
Increased shares by 4653.6% (+3.42 Million shares)
Q4 2023
Avg closing price
$2.36
Price range
$1.65
-
$3.94
Increased shares by 624.2% (+63.3 Thousand shares)
Q3 2023
Avg closing price
$3.31
Price range
$2.02
-
$5.04
New holding (+10.1 Thousand shares)
Q2 2023
Avg closing price
$5.52
Price range
$4.76
-
$6.59
Sold -152 Thousand shares
Q4 2020
Avg closing price
$62.10
Price range
$38.09
-
$100.95
Sold 53.6% shares (-175 Thousand shares)
Q3 2020
Avg closing price
$34.92
Price range
$30.41
-
$40.50
New holding (+327 Thousand shares)
Q2 2020
Avg closing price
$29.80
Price range
$20.21
-
$35.23
Sold -783 Thousand shares
Q1 2020
Avg closing price
$25.29
Price range
$17.28
-
$31.88
Sold 33.7% shares (-397 Thousand shares)
Q4 2019
Avg closing price
$15.88
Price range
$13.39
-
$20.73
Increased shares by 98.8% (+587 Thousand shares)
Q3 2019
Avg closing price
$19.17
Price range
$15.47
-
$22.50
Increased shares by 18.7% (+93.5 Thousand shares)
Q2 2019
Avg closing price
$18.02
Price range
$15.61
-
$20.44
New holding (+500 Thousand shares)
Q1 2019
Avg closing price
$15.78
Price range
$13.15
-
$18.71
